OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells remains a paramount challenge to the biopharmaceutical industry. A variety of strategies have been employed to antibody titer, including process parameter optimization, cell line development, and adoption of perfusion processes. Fine-tuning culture conditio